|
|
|
|
||
Cooper is playing D The proxy solicitors are undoubtedly informing ZIOP management that the overwhelming tide of submitted votes is running hard against validating the board and management's proposals. The good doctor is most likely reaching out for one-on-one conversations with larger shareholders and trying to persuade them to back the folly of his mis-management. I'm sure he's being joined by certain members of the board. Tariff's head is undeniably on a platter and no doubt he's dialing for his dollars as well. Such steps and machinations are common-place when corporate dissidents are strong and may gain the upper-hand in proxy voting. My guess is that Cooper, et.al. pleading will go for naught. Too many have lost patience with his pattern of verbal obfuscation and overpromising. Too many have finally seen his blindness to the poor optics of unwarranted bonuses and lack of personal investment in the company (not ever even a symbolic share purchase). Couple this with his new highfalutin lifestyle and enlarged corporate spending and you have a recipe for rejection. We all (save for a few ostriches) understand that Cooper has proven himself wildly mismatched as a responsible corporate CEO. It is entirely reasonable and fair for a bright person to take the leap and try their hand in a different role in life. No doubt whatsoever that Cooper was handed the reigns to ZIOP by RJ Kirk with the Kirk's belief he would rise to the occasion. Sadly, Lawrence Cooper has failed at this role. His experience and expertise was best matched with a white lab coat, not a suit and tie. The time for this experiment is over. His future with ZIOP isn't necessarily a binary choice at this point. He's undeniably a valuable asset to the company, and most certainly can play a constructive role, yet the question at hand is just how large and fragile his ego is? It'll be fascinating to see what happens should he be voted off the Board of Directors and/or offered a title demotion (and/or compensation reduction)? Like any good poker game, we'll see whether he just folds and leaves the game or re-seats himself at the table and asks to be dealt in? His choice will speak volumes about the true prospects for Ziopharm. All of us should be ready for an increase in ZIOP's share volatility. Large existing shareholders, and fresh new capital may well take steps to shuffle or establish new positions. While I could be (and often enough am) wrong, I expect the stock's recent tightly-wound range-bound trading to expand at the time of the end of the vote, and ultimately trade higher after things settle out. We shall see. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
113906 | Re: Cooper is playing D | Ubmmg | 0 | 6/4/2020 8:32:25 AM |
113907 | Re: Cooper is playing D | raferjack | 12 | 6/4/2020 9:30:35 AM |
113910 | Re: Cooper is playing D | biolurker1 | 1 | 6/4/2020 11:16:36 AM |